Don Weissman, MD 

Weissman Associates
LifeSciences and Healthcare

Strategic Business Development
 

Medical Affairs - KOL Governance

 

Senior Medical Science Liaison

 

Initiatives, Alliances, Partnerships

Commercial Optimization

                                                       

 

  

"A MISSION OF BETTER HEALTH"


Highly accomplished Physician, Director Medical Affairs,

Senior Medical Science Liaison and Strategic Business Development


 

Outstanding "C level" relationships and success
helping LifeScience Companies and Healthcare Institutions 
accelerate product development and optimize market
share for Patient benefits, Society and Stakeholder values
.

 

 

Exceptional education, presentation and communication skills for
Key Opinion Leader insights, applications, clinical trials and advocacy,
Advisory Board Development and collaborative relationships with
 internal and external partnerships
top tier Academic Medical Centers,
Physicians, 
Hospitals and Institutions of Excellence. 

 
 

Analyst and panel review member for the National Science Foundation,
the National Institute of Health and the Department of
Health and Human Services in biomedical research, diagnostics, genomics
bio-pharmaceuticals and innovative therapeutics.


An adept listener with a wealth of knowledge, understanding and
applications of
market needs, drivers and dynamics. Experienced in 
regulatory affairs,
pharmacoeconomics and vigilance for resource
allocation and
guidelines with the FDA, FTC, AHRQ and CMS.
Proven track
record of success for coverage and reimbursements 
by major
payers, providers and plans.
 
 

Honored society, academic and board memberships for strategic CME,
regional and national symposia, influential peer review publications, brand
and market development with mobile, social media
applications and validation. 

 
 
 

Extraordinary resources, experience and motivational skills building 
professional consensus with notable academic, research and clinical
leadership for optimal patient care and outcomes,
society and stakeholder values.

 

GOALS:

 

                

Innovative therapeutics, diagnostics and services

to treat, ameliorate, cure and prevent.


 

To optimize patient well being and quality of life
with excellence
in clinical, operational and financial outcomes. 


 
  

 http://www.med.upenn.edu/aging/IOAExternalAdvisory
Boardbios7.shtml#weissman

 

 

https://plus.google.com/108427295089655199047

 

tw: DrDonMD